nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv qikanlogo popupnotification paper paperNew
2025, 10, v.65 8-13
代谢相关脂肪性肝病合并结直肠腺瘤性息肉的影响因素分析及预测模型构建
基金项目(Foundation):
邮箱(Email): xfzb888@126.com;yzwsdta@163.com;
DOI:
摘要:

目的 分析代谢相关脂肪性肝病(MAFLD)合并结直肠腺瘤性息肉(CAP)的影响因素,并构建预测模型。方法 选取MAFLD患者180例,其中102例经结肠镜检查及病理证实为CAP,记为MAFLD+CAP组;78例经结肠镜检查大致正常,记为MAFLD组。收集并比较两组患者的基本资料,包括性别、年龄、高血压史、吸烟史、饮酒史、粪便隐血试验结果、血红蛋白、血小板分布宽度、空腹血糖、小而密低密度脂蛋白胆固醇(sdLDL-C)等40个指标。采用Logistic回归分析法分析MAFLD合并CAP的影响因素,并构建MAFLD合并CAP的预测模型,采用受试者工作特征(ROC)曲线评估预测模型对MAFLD合并CAP的预测价值。应用R 4.2.0软件,绘制校准曲线评估模型的一致性。采用Bootstrap法重复抽样1 000次进行模型的内部验证,采用Hosmer-Lemeshow检验评估模型的准确度。结果 MAFLD+CAP组年龄、性别、高血压病史、吸烟史、饮酒史、粪便隐血试验结果、血红蛋白水平、血小板分布宽度、空腹血糖水平、sdLDL-C水平等资料,与MAFLD组相比,P均<0.05。性别、年龄、粪便隐血试验结果、sdLDL-C是MAFLD合并CAP的独立影响因素(P均<0.05)。据此构建了MAFLD合并CAP的预测模型P=1/(1+e-Y),其中P表示MAFLD合并CAP的概率,e为自然底数,Y=1.104×性别+1.236×粪便隐血试验+0.078×年龄+1.126×sdLDL-8.207,性别变量中男性为1、女性为0,粪便隐血试验(弱)阳性为1、阴性为0。预测模型的AUC为0.780,灵敏度为63.7%,特异度为78.2%。预测模型的校准曲线比较贴近理想曲线。预测模型的实际概率与预测概率比较,差异无统计学意义(P=0.233)。结论 性别、年龄、粪便隐血试验结果、sdLDL-C是MAFLD合并CAP的独立影响因素,基于上述影响因素构建的预测模型对MAFLD患者合并CAP的风险具有较高的预测价值。

Abstract:

Objective To analyze the risk factors for metabolic dysfunction-associated fatty liver disease(MAFLD) complicated with colorectal adenomatous polyps(CAP) and to construct a corresponding risk prediction model. Methods A total of 180 MAFLD patients were enrolled, including 102 cases with CAP(MAFLD+CAP group) and 78 cases without CAP(MAFLD group). We collected and compared the basic data of patients of the two groups, including 40 indicators of gender, age, hypertension, smoking, alcohol consumption, fecal occult blood test results, hemoglobin, platelet distribution width, fasting blood glucose, small dense low-density lipoprotein cholesterol(sdLDL-C), etc. Logistic Regression analysis was used to identify the influencing factors of MAFLD combined with CAP, and a predictive model was subsequently constructed. The predictive value of the model for MAFLD with CAP was evaluated using the receiver operating characteristic(ROC) curve. A calibration curve was plotted by using R 4. 2. 0 software to evaluate the consistency of the model. Internal validation of the model was performed by resampling 1,000 times using the Bootstrap method, and model accuracy was assessed using the Hosmer-Lemeshow test. Results Statistically significant differences were found in the data such as age, sex, history of hypertension, smoking history, drinking history, fecal occult blood test results, hemoglobin, platelet distribution width, fasting blood glucose, sdLDL-C, and others between the MAFLD+CAP group and MAFLD group(all P<0. 05). Sex, age, fecal occult blood test results, and sdLDL-C were identified as the independent risk factors for MAFLD combined with CAP(all P<0. 05). The risk prediction model based on these factors was formulated as P=1/(1 + e-Y), where Y=1. 104 × sex + 1. 236 × fecal occult blood test + 0. 078 × age + 1. 126 × sdLDL-8. 207, with sex(male=1, female=0) and fecal occult blood test [(weakly) positive=1, negative=0]. The area under the ROC curve(AUC) of the prediction model was 0. 780, with a sensitivity of 63. 7%, and a specificity of 78. 2%. The calibration curve of the predictive model was close to the ideal curve. Hosmer-Lemeshow test analysis showed no statistically significant difference between the predicted and actual probabilities(P=0. 233), indicating good model fit. Conclusions Male sex, age,(weakly) positive fecal occult blood test, and sdLDL-C are risk factors for MAFLD complicated with CAP. The prediction model constructed in this study has a high predictive value.

参考文献

[1]胡志强,游伟程,潘凯枫,等.中、美两国癌症流行特征分析——《2023美国癌症统计报告》解读[J].科技导报,2023,41(18):18-28.

[2]陈星宇,孔令斌.结直肠腺瘤性息肉癌变相关因素及机制研究进展[J].中华肿瘤防治杂志,2019,26(5):354-358.

[3] ESLAM M, SARIN S K, WONG V W, et al. The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease[J]. Hepatol Int, 2020,14(6):889-919.

[4] RINELLA M E, LAZARUS J V, RATZIU V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature[J]. Hepatology, 2023,78(6):1966-1986.

[5]杨蕊旭,范建高.非酒精性脂肪性肝病新认识与再更名[J].临床肝胆病杂志,2023,39(8):1775-1779.

[6]杨小艳,杨勇,张旭,等.非酒精性脂肪性肝病与冠状动脉易损斑块的关系研究[J].中国全科医学,2018,21(31):3827-3831.

[7]黄翔谦,闫晓檬,张明达,等.非酒精性脂肪性肝病与结直肠肿瘤的相关性[J].临床肝胆病杂志,2021,37(12):2947-2950.

[8]王东旭,邢川,吕波,等.多囊卵巢综合征合并非酒精性脂肪性肝病的危险因素[J].临床肝胆病杂志,2021,37(10):2474-2477.

[9]章雅南,刘奕婷.非酒精性脂肪性肝病患者肝纤维化程度与慢性肾病的相关性[J].中国老年学杂志,2021,41(19):4214-4218.

[10]雷偲艺,连莉优,郑明华.《2025年亚太肝病学会临床实践指南:代谢相关脂肪性肝病的诊断和管理》摘译与解读[J].临床肝胆病杂志,2025,41(6):1043-1052.

[11]范建高,徐小元,南月敏,等.代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J].实用肝脏病杂志,2024,27(4):494-510.

[12] ZHOU J, ZHOU F, WANG W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020,71(5):1851-1864.

[13] HUANG K W, LEU H B, WANG Y J, et al. Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy[J].Colorectal Dis, 2013,15(7):830-835.

[14] BLACKETT J W, VERNA E C, LEBWOHL B. Increased prevalence of colorectal adenomas in patients with nonalcoholic fatty liver disease:a cross-sectional study[J]. Dig Dis, 2020,38(3):222-230.

[15]程芮,龚芮,姜维,等.中老年结直肠息肉患者的临床病理特征及腺瘤性息肉的危险因素分析[J].肿瘤防治研究,2025,52(1):19-24.

[16] STOFFEL E M, MURPHY C C. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults[J]. Gastroenterology, 2020,158(2):341-353.

[17]汤锦洪,王龙.非酒精性脂肪性肝病与结直肠腺瘤性息肉相关性的研究进展[J].临床肝胆病杂志,2021,37(11):2672-2675.

[18] DITONNO I, LOSURDO G, RENDINA M, et al. Estrogen receptors in colorectal cancer:facts, novelties and perspectives[J].Curr Oncol, 2021,28(6):4256-4263.

[19]刘梦茹,戴夫,彭琼.非酒精性脂肪性肝病及其肝纤维化程度与结直肠腺瘤性息肉的关系[J].中国中西医结合消化杂志,2022,30(1):36-41.

[20]漆道西,郑芳.小而密低密度脂蛋白胆固醇与2型糖尿病微血管病变的相关性分析[J].临床检验杂志,2022,40(7):510-515.

[21]闫炜,郭丹,孙晓婷. 2型糖尿病合并非酒精性脂肪肝患者血清小而密低密度脂蛋白变化及与胰岛素抵抗脂肪衰减指数的关系分析[J].河北医学,2023,29(11):1868-1872.

[22] CORNISH A J, LAW P J, TIMOFEEVA M, et al. Modifiable pathways for colorectal cancer:a mendelian randomisation analysis[J]. Lancet Gastroenterol Hepatol, 2020,5(1):55-62.

[23] WANG X, ZOU Y, ZHANG R, et al. The relationship between serum lipid levels and colorectal serrated lesions:a systematic review and meta-analysis[J]. Front Physiol, 2022,13:984586.

[24] GAO Y, WANG J, ZHOU Y, et al. Evaluation of serum CEA,CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer[J]. Sci Rep,2018,8(1):2732.

[25] RASMUSSEN L, NIELSEN H J, CHRISTENSEN I J. Early detection and recurrence of colorectal adenomas by combination of eight cancer-associated biomarkers in plasma[J]. Clin Exp Gastroenterol, 2020,13:273-284.

基本信息:

DOI:

中图分类号:R735.34;R575.5

引用信息:

[1]张丹芃,史伟伟,肖锋,等.代谢相关脂肪性肝病合并结直肠腺瘤性息肉的影响因素分析及预测模型构建[J].山东医药,2025,65(10):8-13.

基金信息:

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文